e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
State Street SPDR S&P Biotech ETF
(NY:
XBI
)
124.78
-1.96 (-1.55%)
Official Closing Price
Updated: 4:10 PM EST, Feb 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
13,353,561
Open
124.82
Bid (Size)
124.51 (1,000)
Ask (Size)
124.75 (500)
Prev. Close
126.74
Today's Range
122.94 - 125.60
52wk Range
66.66 - 132.09
Shares Outstanding
541,500
Dividend Yield
1.30%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
ImmunityBio Inks Partnerships To Launch Cancer Drug In Saudi Arabia Amid Expansion Efforts
↗
Today 12:45 EST
ImmunityBio announced that it has partnered with Biopharma and Cigalah and hopes to launch Anktiva across the broader Middle East and North Africa (MENA) region over time.
Via
Stocktwits
ARDX Stock Is Down Pre-Market After Q4 Earnings Miss, So Why Did This Firm Just Hike Price Target By 80%?
↗
Today 7:43 EST
Analysts at H.C. Wainwright hiked their price target for Ardelyx shares to $18 from $10.
Via
Stocktwits
Topics
Earnings
Intellectual Property
Performance
YTD
+2.7%
+2.7%
1 Month
-0.4%
-0.4%
3 Month
+9.6%
+9.6%
6 Month
+38.8%
+38.8%
1 Year
+34.9%
+34.9%
More News
Read More
GRAL Stock Slumps After Hours As Trial For Cancer Test Fails To Show Reduction In Late-Stage Diagnoses
↗
February 19, 2026
Via
Stocktwits
Topics
Artificial Intelligence
Death
ARDX Stock Slips After Hours As Q4 Earnings Disappoint: Retail Sees Ibsrela Driving Outperformance In Time
↗
February 19, 2026
Via
Stocktwits
Topics
Artificial Intelligence
Why IBRX Stock Is One Of The Biggest Pre-Market Movers Today
↗
January 16, 2026
Via
Stocktwits
IBRX Stock Finds Retail Cheer After Company’s Immunotherapy For Bladder Cancer Gets Saudi FDA Approval
↗
January 14, 2026
Via
Stocktwits
Why Did NRXP Stock Surge 21% Pre-Market Today?
↗
January 14, 2026
Via
Stocktwits
ImmunityBio Announces Partnership To Expand Access To Anktiva Across 30 Countries
↗
February 19, 2026
Via
Stocktwits
SNSE Stock Surges To 21-Month High – Everything To Know About Its Faeth Therapeutics Acquisition
↗
February 18, 2026
Via
Stocktwits
IBRX Gains 30% On Fresh Approval For Bladder Cancer Drug In EU: Retail, Wall Street Eyes Further Rally
↗
February 18, 2026
Via
Stocktwits
IBRX Stock Jumps 6% Pre-Market On BCG Update In Saudi Arabia – Retail Says Share Price Is ‘Attractive’
↗
February 17, 2026
Via
Stocktwits
IBRX Garners Retail Attention On Positive Update In Immunotherapy For Lung Cancer Patients
↗
January 13, 2026
Via
Stocktwits
Why Did TVTX Stock Crash 30% In Pre-Market Today?
↗
January 13, 2026
Via
Stocktwits
IBRX Stokes Retail Chatter — Investors See Anktiva Beat Merck’s Keytruda With Approval In EU
↗
February 13, 2026
Via
Stocktwits
RARE Stock Slumps On Multiple Wall Street Price Target Slashes, Clinical Pipeline Uncertainty
↗
February 13, 2026
Via
Stocktwits
VKTX Stock Rallies After Hours On Optimism Around Company’s Obesity Pipeline
↗
February 11, 2026
Via
Stocktwits
Biotech Beat Nvidia in 2025. Can It Do It Again?
↗
February 11, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now
↗
February 11, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Economy
Why Did UPB Stock Pop 20% In Pre-Market Today?
↗
February 11, 2026
Via
Stocktwits
Why Did RGNX Shares Plummet 19% After-Hours Today?
↗
February 09, 2026
Via
Stocktwits
MDXG Stock Rises As MiMedx Enters Into Exclusive Distribution Agreement For Three Products
↗
February 04, 2026
Via
Stocktwits
Topics
Artificial Intelligence
RGNX Stock Is Falling Today — What Is The FDA Update On REGENXBIO's Gene Therapy?
↗
January 28, 2026
Via
Stocktwits
Why Did MNKD Stock Jump Over 7% In Pre-Market Today?
↗
January 26, 2026
Via
Stocktwits
The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
January 22, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Initial Public Offering
Why NVAX Stock Is Popping Pre-Market – And What Does Pfizer Have To Do With It?
↗
January 20, 2026
Via
Stocktwits
Frequently Asked Questions
Is State Street SPDR S&P Biotech ETF publicly traded?
Yes, State Street SPDR S&P Biotech ETF is publicly traded.
What exchange does State Street SPDR S&P Biotech ETF trade on?
State Street SPDR S&P Biotech ETF trades on the New York Stock Exchange
What is the ticker symbol for State Street SPDR S&P Biotech ETF?
The ticker symbol for State Street SPDR S&P Biotech ETF is XBI on the New York Stock Exchange
What is the current price of State Street SPDR S&P Biotech ETF?
The current price of State Street SPDR S&P Biotech ETF is 124.78
When was State Street SPDR S&P Biotech ETF last traded?
The last trade of State Street SPDR S&P Biotech ETF was at 02/20/26 04:10 PM ET
What is the market capitalization of State Street SPDR S&P Biotech ETF?
The market capitalization of State Street SPDR S&P Biotech ETF is 67.57M
How many shares of State Street SPDR S&P Biotech ETF are outstanding?
State Street SPDR S&P Biotech ETF has 68M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.